News
Swiss drugmaker Roche is petitioning the U.S. government in direct talks for import tariff exemptions, arguing the products ...
Roche posted a Q1 revenue beat, with strong contributions from Phesgo, Xolair, and Polivy, despite larger products lagging.
Roche will invest $50 billion in U.S. manufacturing, including a new plant in Indiana. The Trump administration is ...
Roche reported flat Q1 sales for its diagnostic division, citing headwinds in China, but reaffirmed the market’s strategic ...
Roche’s exposure to the tariffs is mostly limited to four medicines, three of which it already produces in the U.S., ...
The pharma giant said the investment would create more than 12,000 jobs, as it joins rival Novartis in expanding its ...
The move will also create 12,000 new jobs across the United States, with 6,500 in construction and 1,000 at “new and expanded ...
Roche said on Tuesday it would invest $50 billion in the United States over the next five years, creating more than 12,000 ...
The Basel-based company said the investment would go toward high-tech research and development sites and new manufacturing ...
Roche is working to mitigate potential impacts from tariffs by moving production of its medicines to the U.S. and petitioning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback